Literature DB >> 22024039

Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?

Yong Liu1, Xi-Hai Chen, Xian-Hong Meng, Chun-Fu Liu, Li-Li Zhao, Ji-Wu Han, Li-Wei Zhuang.   

Abstract

BACKGROUND/AIMS: We analyzed the clinicopathological factors of patients with node-positive gastric cancer, evaluated the prognostic factors associated with long-term survival and clarified the effect of tumor size on long-term survival.
METHODOLOGY: The study included 591 patients who underwent curative resection for node-positive gastric cancer. Clinicopathological prognostic variables were evaluated as predictors of long-term survival by univariate and multivariate analyses.
RESULTS: The 5-year survival rate was influenced by tumor size, tumor location, depth on invasion, level of lymph node metastasis, Borrmann classification, histological type, liver metastasis, peritoneal dissemination and disease stage. Of these, independent prognostic factors were depth on invasion and lymph node metastasis. Tumor size is an influence but not independent factor for the prediction of long-term survival in patients with node-positive gastric cancer.
CONCLUSIONS: In patients with node-positive gastric cancer, two independent prognostic factors were depth on invasion and the status of lymph node metastasis.

Entities:  

Mesh:

Year:  2012        PMID: 22024039     DOI: 10.5754/hge11455

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Prognostic role of lymph node metastasis in early gastric cancer.

Authors:  Zhixue Zheng; Yiqiang Liu; Zhaode Bu; Lianhai Zhang; Ziyu Li; Hong Du; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2014-04       Impact factor: 5.087

2.  Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection.

Authors:  Jeong Won Lee; Sang Mi Lee; Moon-Soo Lee; Hyeong Cheol Shin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-07       Impact factor: 9.236

3.  The presence of metastases in regional lymph nodes is associated with tumor size and depth of invasion in sporadic gastric adenocarcinoma.

Authors:  Eduardo Cambruzzi; Andreza Mariane de Azeredo; Ardala Kronhart; Katia Martins Foltz; Claudio Galeano Zettler; Karla Lais Pêgas
Journal:  Arq Bras Cir Dig       Date:  2014 Jan-Mar

4.  A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.

Authors:  Jing Qian; Yingying Qian; Jian Wang; Bing Gu; Dong Pei; Shaohua He; Fang Zhu; Oluf Dimitri Røe; Jin Xu; Lianke Liu; Yanhong Gu; Renhua Guo; Yongmei Yin; Yongqian Shu; Xiaofeng Chen
Journal:  Drug Des Devel Ther       Date:  2016-02-24       Impact factor: 4.162

5.  Survival of gastric cancer patients based on pathologic and demographic characteristics in Mazandaran between 2007 and 2013.

Authors:  Abolfazl Nikpour; Alireza Khalilian; Iradj Maleki; Hossein Mohsenipouya; Jamshid Yazdani Charati
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

6.  Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study.

Authors:  Chen Xiaobin; Xu Zhaojun; Liu Tao; Dai Tianzeng; Huang Xuemei; Zheng Fan; Huang Chunyin; Huang Jianqiang; Lin Chen
Journal:  J Immunol Res       Date:  2022-02-15       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.